• Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.

      Else, L J; Jackson, V; Brennan, M; Back, D J; Khoo, S H; Coulter-Smith, S; Lambert, J S; Rotunda Hospital Dublin (2014-11)
      Pregnant women experience physiological changes during pregnancy that can have a significant impact on antiretroviral pharmacokinetics. Ensuring optimal plasma concentrations of antiretrovirals is essential for maternal health and to minimize the risk of vertical transmission. Here we describe atazanavir/ritonavir (ATV/r) plasma concentrations in a cohort of pregnant women undergoing routine therapeutic drug monitoring (TDM).